Published July 25, 2017 4:57pm EDT | Updated July 25, 2017 5:03pm EDT

Celgene Corp. to pay $280 million to settle lawsuit alleging it promoted cancer drugs for unapproved uses

LOS ANGELES – Celgene Corp. to pay $280 million to settle lawsuit alleging it promoted cancer drugs for unapproved uses.